Literature DB >> 646542

Hypercalcemic nephropathy.

J E Benabe, M Martinez-Maldonado.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646542

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  16 in total

1.  Thiazide therapy and severe hypercalcemia in a patient with hyperparathyroidism.

Authors:  P Strong; S Jewell; J Rinker; D Hoch; L Crapo
Journal:  West J Med       Date:  1991-03

Review 2.  Assessment of renal and skeletal components of hypercalcemia.

Authors:  D J Hosking
Journal:  Calcif Tissue Int       Date:  1990       Impact factor: 4.333

3.  Sarcoidosis presenting with an unusual erythematous rash and persistent hypercalcemia.

Authors:  B L Barney
Journal:  West J Med       Date:  1992-05

4.  Renal handling of calcium and sodium in metastatic and non-metastatic malignancy.

Authors:  S R Heller; D J Hosking
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-01

5.  Disequilibrium hypercalcaemia.

Authors:  D J Hosking
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-29

6.  Management of severe hypercalcaemia.

Authors: 
Journal:  Br Med J       Date:  1980-01-26

Review 7.  Hypercalcaemia of malignancy.

Authors:  P J Kelly; J A Eisman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

8.  Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.

Authors:  D J Hosking; S R Heller
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 9.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Hypercalcaemia-induced acute renal failure as a presenting feature of T-cell leukaemia.

Authors:  M Lishner; A Pomeranz; E Rozenbaum; Z Korzets; L Shenkman
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.